Target intelligence / Profile preview

Redox and metabolic pathways

Molecular classification
Other
01

Overview

Redox and metabolic pathways encompass the integrated network of biochemical reactions responsible for energy conversion and the maintenance of cellular oxidative balance. These pathways, including glycolysis, the citric acid cycle, and oxidative phosphorylation, are fundamental to all cellular life and are tightly regulated to ensure homeostasis (Source: Nature Reviews Molecular Cell Biology, 2018). In various pathologies, such as cancer, cells undergo metabolic reprogramming to support rapid proliferation and survival under stress, often by altering redox signaling (Source: Cell Metabolism, 2020). While the term refers to a broad biological system rather than a single protein, many specific enzymes within these pathways serve as critical therapeutic targets. Drugs interacting with these systems aim to exploit metabolic vulnerabilities or restore redox equilibrium to treat conditions ranging from metabolic disorders to malignancy (Source: Pharmacological Reviews, 2017). For instance, targeting the redox balance can sensitize tumor cells to chemotherapy or radiation. Additionally, metabolic modulators like metformin are widely used to manage systemic glucose levels in diabetic patients. Understanding the crosstalk between these pathways is essential for developing precision medicines that minimize off-target effects on healthy tissues.

Other names
Cellular metabolismOxidation-reduction signalingMetabolic networksRedox homeostasisEnergy metabolism
02

Mechanism of action

Modulation of enzymatic activity within metabolic cycles, regulation of reactive oxygen species (ROS) levels, and alteration of substrate availability for energy production.

03

Biological functions

MetabolismOxidation-reductionEnergy productionCellular homeostasisSignal transductionNutrient sensing
04

Disease associations

CancerDiabetes mellitusNeurodegenerative diseaseCardiovascular diseaseMetabolic syndromeMitochondrial disorders
05

Safety considerations

Systemic metabolic disruptionPotential for mitochondrial toxicityOff-target effects on healthy tissue metabolismNarrow therapeutic window for redox modulatorsRisk of lactic acidosis
06

Interacting drugs

Metformin

5 more in the full profile.

07

Biomarkers

Reactive oxygen species (ROS) levelsNAD+/NADH ratioGlutathione (GSH/GSSG) ratioLactate levelsBlood glucose8-Hydroxy-2-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on Redox and metabolic pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redox and metabolic pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call